| An investigation into the utility of a multi-compartmental, dynamic, system of the upper gastrointestinal tract to support formulation development and establish bioequivalence … PA Dickinson, R Abu Rmaileh, L Ashworth, RA Barker, WM Burke, ... The AAPS journal 14 (2), 196-205, 2012 | 122 | 2012 |
| Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge M Sánchez-Félix, M Burke, HH Chen, C Patterson, S Mittal Advanced drug delivery reviews 167, 66-77, 2020 | 98 | 2020 |
| Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy CM Patterson, SB Balachander, I Grant, P Pop-Damkov, B Kelly, ... Communications Biology 4 (1), 112, 2021 | 74 | 2021 |
| IMI–Oral biopharmaceutics tools project–Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling … A Ahmad, X Pepin, L Aarons, Y Wang, AS Darwich, JM Wood, ... European Journal of Pharmaceutics and Biopharmaceutics 156, 50-63, 2020 | 25 | 2020 |
| An investigation into the influence of drug lipophilicity on the in vivo absorption profiles from subcutaneous microspheres and in situ forming depots CM Deadman, IW Kellaway, M Yasin, PA Dickinson, S Murdan Journal of controlled release 122 (1), 79-85, 2007 | 21 | 2007 |
| Nonclinical safety and pharmacokinetics of Miglyol 812: A medium chain triglyceride in exenatide once weekly suspension N Buss, P Ryan, T Baughman, D Roy, C Patterson, C Gordon, R Dixit Journal of Applied Toxicology 38 (10), 1293-1301, 2018 | 8 | 2018 |
| The global characterisation of a drug-dendrimer conjugate-PEGylated poly-lysine dendrimer N Akhtar, MB Ashford, L Beer, A Bowes, T Bristow, A Broo, D Buttar, ... Journal of Pharmaceutical Sciences 112 (3), 844-858, 2023 | 6 | 2023 |
| Determining bioequivalence possibilities of long acting injectables through population PK modelling P Gajjar, J Dickinson, H Dickinson, L Ruston, HB Mistry, C Patterson, ... European Journal of Pharmaceutical Sciences 179, 106296, 2022 | 6 | 2022 |
| In depth characterization of physicochemical critical quality attributes of a clinical drug-dendrimer conjugate S Sonzini, F Caputo, D Mehn, L Calzolai, SE Borgos, A Hyldbakk, ... International Journal of Pharmaceutics 637, 122905, 2023 | 2 | 2023 |
| Biopharmaceutics of Injectable Formulations WW Lee, CM Patterson Biopharmaceutics: From Fundamentals to Industrial Practice, 253-263, 2022 | 2 | 2022 |
| Novel application of synchrotron x-ray computed tomography for ex-vivo imaging of subcutaneously injected polymeric microsphere suspension formulations C Patterson, D Murphy, S Irvine, L Connor, Z Rattray Pharmaceutical Research 37, 1-11, 2020 | 2 | 2020 |
| Biopharmaceutical studies of slow release, subcutaneous polymeric drug delivery systems CM Deadman PQDT-Global, 2006 | 1 | 2006 |
| Population PK modelling as an alternative route to bioequivalence P Gajjar, J Dickinson, H Dickinson, L Ruston, HB Mistry, C Patterson, ... British Journal of Pharmacy 7 (2), S1-S2, 2022 | | 2022 |
| Development of a methodology to enable non-linear in vitro-in vivo correlation for complex long-acting injections\ J Dickinson, C Patterson, P Gajjar, H Dickinson, PA Dickinson preparation, 0 | | |
Paul A DickinsonSeda Pharmaceutical Development ServicesVerified email at sedapds.com
